Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Wolfgang, Hinkelbein"'
Autor:
Lorenzo Tosco, Giorgio Gandaglia, Shahrokh F. Shariat, Paolo Dell'Oglio, Thomas Seisen, Claudio Fiorino, Marco Moschini, Steven Joniau, Hein Van Poppel, Alberto Bossi, Gregor Goldner, Nicola Fossati, Barbara Noris Chiorda, Karin Haustermans, Francesco Montorsi, Alessandro Morlacco, Alberto Briganti, Wolfgang Hinkelbein, Stephen A. Boorjian, Detlef Bartkowiak, R. Jeffrey Karnes, Bertrand Tombal, Thomas Wiegel, Cesare Cozzarini
Background Three prospective randomised trials reported discordant findings regarding the impact of adjuvant radiation therapy (aRT) versus observation for metastasis-free survival (MFS) and overall survival (OS) among patients with pT3N0 prostate ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ed02fad0e1190f90ed9bd7d4abd2f8
http://hdl.handle.net/11577/3291129
http://hdl.handle.net/11577/3291129
Autor:
Stefan Höcht, Gunnar Lohm, Basil Jamil, Thomas Wiegel, Dirk Bottke, Konrad Neumann, Jörg Lütcke, Wolfgang Hinkelbein
Publikováno v:
Strahlentherapie und Onkologie. 190:727-731
In patients with prostate cancer (PC) and biochemical relapse after radical prostatectomy, salvage radiotherapy (SRT) could improve PC-specific survival (PCSS) but the timing for initiation is still under discussion. We have demonstrated a low rate o
Autor:
Kurt Miller, Stephan Störkel, Lothar Hertle, Dirk Bottke, Thomas Wiegel, Wolfgang Hinkelbein, Alessandra Siegmann, Reinhard Golz, Axel Hinke
Publikováno v:
European Urology. 64:193-198
Background In a randomised trial, radical prostatectomy (RP) followed by adjuvant radiotherapy (aRT) was compared with RP alone in patients with pT3 pN0 prostate cancer with or without positive margin at local pathology (German Cancer Society trial n
Autor:
Thomas, Wiegel, Wolfgang, Hinkelbein
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 192(8)
Autor:
Wolfgang Hinkelbein, Claudio Fiorino, Nicola Fossati, Hendrik Van Poppel, Thomas Wiegel, Giorgio Gandaglia, Alberto Briganti, Karin Haustermans, Dirk De Ridder, Lorenzo Tosco, Jeffrey Karnes, Marco Moschini, Alberto Bossi, Francesco Montorsi, Cesare Cozzarini, Bertrand Tombal, Barbara Noris Chiorda, Steven Joniau, Stephen A. Boorjian, Shahrokh F. Shariat, Alessandro Morlacco, Thomas Seisen, Gregor Goldner
Publikováno v:
Journal of Urology. 195
INTRODUCTION AND OBJECTIVES: Prostate cancer (PCa) patients with seminal vesicle invasion (SVI) are at increased risk of recurrence and mortality after radical prostatectomy (RP). We aimed at assessing the impact of adjuvant radiotherapy (aRT) on can
Autor:
Nicola Fossati, Jeffrey R. Karnes, Alessandro Morlacco, Marco Moschini, Stephen A. Boorjian, Thomas Seisen, Alberto Bossi, Cesare Cozzarini, Claudio Fiorino, Barbara Noris Chiorda, Giorgio Gandaglia, Lorenzo Tosco, Dirk De Ridder, Steven Joniau, Gregor Goldner, Shahrokh François Shariat, Wolfgang Hinkelbein, Karin Haustermans, Bertrand Tombal, Francesco Montorsi, Hein Van Poppel, Thomas Wiegel, Alberto Briganti
Publikováno v:
Journal of Urology. 195
Autor:
Hendrik Van Poppel, Cesare Cozzarini, Thomas Wiegel, Karin Haustermans, Wolfgang Hinkelbein, Jeffrey Karnes, Gregor Goldner, Thomas Seisen, Dirk De Ridder, Stephen A. Boorjian, Giorgio Gandaglia, Marco Moschini, Alessandro Morlacco, Nicola Fossati, Barbara Noris Chiorda, Lorenzo Tosco, Claudio Fiorino, Shahrokh F. Shariat, Steven Joniau, Alberto Briganti, Alberto Bossi, Bertrand Tombal, Francesco Montorsi
Publikováno v:
Journal of Urology. 195
Autor:
Kurt Miller, Dirk Bottke, Basil Jamil, Thomas Wiegel, Konrad Neumann, Wolfgang Hinkelbein, Gunnar Lohm, Detlef Bartkowiak
Publikováno v:
World Journal of Urology. 31:423-428
Salvage radiotherapy (SRT) is applied routinely in patients with a biochemical relapse after radical prostatectomy (RP). Although the detection threshold for relapse after RP has steadily been lowered, only about 30% of the SRT patients achieve a dur
Autor:
Dirk Bottke, Detlef Bartkowiak, Julia Faehndrich, Kurt Miller, Thomas Wiegel, Gunnar Lohm, Wolfgang Hinkelbein, Alessandra Siegmann
Publikováno v:
Strahlentherapie und Onkologie. 187:467-472
The optimal dose for salvage radiotherapy (SRT) after radical prostatectomy (RP) is still not defined. It should be at least 66 Gy. In the present study, the suitability of PSA regression as a selection criterion for an SRT dose escalation to 70.2 Gy
Autor:
Thomas Henkel, Kurt Miller, Frederik Wenz, Thomas Wiegel, Thomas Martin, Dirk Böhmer, Wolfgang Hinkelbein, Felix Sedlmayer
Publikováno v:
Der Urologe. 49:216-220
Der postoperativen adjuvanten Strahlentherapie kommt durch das Vorliegen dreier randomisierter Studien im Stadium pT3R1 besondere Bedeutung zu, da hier eine Uberlebensverlangerung gegenuber der „Wait-and-see-Strategie“ nachgewiesen wurde. Als Alt